Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Chapman

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Journal of Extra-Corporeal Technology|May 10, 2007
Whole blood thrombin: development of a process for intra-operative production of human thrombinVijay Kumar, John R Chapman
The Journal of Extra-Corporeal Technology|August 19, 2008
Autologous thrombin: intraoperative production from whole bloodVijay Kumar, John R Chapman
Regulatory Toxicology and Pharmacology : RTP|September 1, 2007
Exposure of hematopoietic stem cells to ethylene oxide during processing represents a potential carcinogenic risk for transplant recipientsByron E Butterworth, John R Chapman
Transfusion|September 26, 2003
Pathogen inactivation of RBCs: PEN110 reproductive toxicology studiesJohn R Chapman, Kristen Moore, Byron E Butterworth
The Journal of Extra-Corporeal Technology|December 25, 2018
An Ethanol-Free Autologous Thrombin SystemAndrea M Matuska, Marina K Klimovich, John R Chapman
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|October 30, 2020
Autologous thrombin preparations: Biocompatibility and growth factor releaseAndrea M Matuska, Marina L Klimovich, Adam W Anz, et al.
Transfusion|March 27, 2004
Development of a sensitive PCR inhibition method to demonstrate HBV nucleic acid inactivationShahika Aytay, Asa Ohagen, Michael R Busch, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Journal of Extra-Corporeal Technology|May 10, 2007
Whole blood thrombin: development of a process for intra-operative production of human thrombinVijay Kumar, John R Chapman
The Journal of Extra-Corporeal Technology|August 19, 2008
Autologous thrombin: intraoperative production from whole bloodVijay Kumar, John R Chapman
Regulatory Toxicology and Pharmacology : RTP|September 1, 2007
Exposure of hematopoietic stem cells to ethylene oxide during processing represents a potential carcinogenic risk for transplant recipientsByron E Butterworth, John R Chapman
Transfusion|September 26, 2003
Pathogen inactivation of RBCs: PEN110 reproductive toxicology studiesJohn R Chapman, Kristen Moore, Byron E Butterworth
The Journal of Extra-Corporeal Technology|December 25, 2018
An Ethanol-Free Autologous Thrombin SystemAndrea M Matuska, Marina K Klimovich, John R Chapman
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|October 30, 2020
Autologous thrombin preparations: Biocompatibility and growth factor releaseAndrea M Matuska, Marina L Klimovich, Adam W Anz, et al.
Transfusion|March 27, 2004
Development of a sensitive PCR inhibition method to demonstrate HBV nucleic acid inactivationShahika Aytay, Asa Ohagen, Michael R Busch, et al.
Pageof 1